Sol-Gel has put in a massive performance over the last year, up around 600% and that's after the recent pull back. That is serious momentum. Based in Israel, they are a dermatology company specializing in treatments for skin conditions using a unique silica-delivery technology.

Fundamentally, there is still optimism here. Just recently, HC Wainwright & Co raised their price target to $110, which is nearly double the current levels. That kind of analyst support often keeps a trend alive. The current pullback looks like standard profit-taking after the explosive move we saw earlier in the month.

Technically, the price action is cooling off. The stock has dipped from its highs but is holding well above the 50-day SMA. The RSI has come down from overbought territory to a more manageable 56. The MACD is crossing down, confirming the pause, but this consolidation could offer a better entry point if buyers step back in.

Given what buyers were very recently prepared to pay for it, and the analysts very recent $100+ target this may well be worth a watch.

..................................................
PLEASE NOTE: Nothing I post is trading advice. All investing involves risk, and past performance doesn’t predict future results. Trends can and do end. For 2026, my goal is to try and post one new asset each day. Something outside the usual gold, silver, BTC, or big tech names. I like to find stocks worldwide showing steady trends with some good gains, a recent pullback, and signs of renewed strength. I don’t necessarily hold positions in these. They are simply companies I find interesting at the time of posting. I’ll often revisit them within a week to see how they went and share any updates. If you enjoy these posts, please BOOST and FOLLOW ME to discover more under-the-radar stocks and businesses from around the world.
..................................................